Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuniko Sunami

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma TissuesKuniko Sunami, Koh Furuta, Koji Tsuta, et al.
International Journal of Clinical Oncology|May 6, 2026
Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT databaseDaisuke Kawauchi, Makoto Ohno, Masamichi Takahashi, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2015
Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancerYuki Katsuya, Yutaka Fujiwara, Kuniko Sunami, et al.
Molecular Cancer Therapeutics|November 28, 2022
High-Throughput Functional Evaluation of MAP2K1 Variants in CancerSho Mizuno, Masachika Ikegami, Takafumi Koyama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 21, 2024
Passive Smoking-Induced Mutagenesis as a Promoter of Lung CarcinogenesisAkifumi Mochizuki, Kouya Shiraishi, Takayuki Honda, et al.
Surgical Neurology International|December 6, 2024
Drug-resistant <i>BRA</i>F V600E-mutant recurrent pleomorphic xanthoastrocytoma, CNS WHO Grade 3 successfully resolved with incidental discontinuation of combined BRAF and MEK inhibitor therapyHirotaka Inoue, Jun-Ichiro Kuroda, Yutaka Fujioka, et al.
The Oncologist|January 16, 2016
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase InhibitorsYoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, et al.
International Journal of Clinical Oncology|January 1, 2021
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in JapanKuniko Sunami, Yoichi Naito, Eriko Aimono, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Medical treatment involving investigational drugs and genetic profile of thymic carcinomaTetsuhiko Asao, Yutaka Fujiwara, Kuniko Sunami, et al.
Japanese Journal of Clinical Oncology|November 9, 2025
Analysis of comprehensive genomic profiling test for Ewing sarcoma in pediatric patients and adults using the nationwide clinical and genomic database in JapanSatoshi Kamio, Koichi Ogura, Yoshiyuki Suehara, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma TissuesKuniko Sunami, Koh Furuta, Koji Tsuta, et al.
International Journal of Clinical Oncology|May 6, 2026
Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT databaseDaisuke Kawauchi, Makoto Ohno, Masamichi Takahashi, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2015
Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancerYuki Katsuya, Yutaka Fujiwara, Kuniko Sunami, et al.
Molecular Cancer Therapeutics|November 28, 2022
High-Throughput Functional Evaluation of MAP2K1 Variants in CancerSho Mizuno, Masachika Ikegami, Takafumi Koyama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 21, 2024
Passive Smoking-Induced Mutagenesis as a Promoter of Lung CarcinogenesisAkifumi Mochizuki, Kouya Shiraishi, Takayuki Honda, et al.
Surgical Neurology International|December 6, 2024
Drug-resistant <i>BRA</i>F V600E-mutant recurrent pleomorphic xanthoastrocytoma, CNS WHO Grade 3 successfully resolved with incidental discontinuation of combined BRAF and MEK inhibitor therapyHirotaka Inoue, Jun-Ichiro Kuroda, Yutaka Fujioka, et al.
The Oncologist|January 16, 2016
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase InhibitorsYoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, et al.
International Journal of Clinical Oncology|January 1, 2021
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in JapanKuniko Sunami, Yoichi Naito, Eriko Aimono, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Medical treatment involving investigational drugs and genetic profile of thymic carcinomaTetsuhiko Asao, Yutaka Fujiwara, Kuniko Sunami, et al.
Japanese Journal of Clinical Oncology|November 9, 2025
Analysis of comprehensive genomic profiling test for Ewing sarcoma in pediatric patients and adults using the nationwide clinical and genomic database in JapanSatoshi Kamio, Koichi Ogura, Yoshiyuki Suehara, et al.
Pageof 7